Our research-based peptides are still the same high-quality peptides youve always known and trusted
Terry reduced the size of his areolas, tightened his chest skin and corrected his tummy tuck, leaving Chase more self-confident in his body
Tirzepatide was developed as a unimolecular dual agonist and moved through the SURPASS (type 2 diabetes) and SURMOUNT (obesity) Phase 3 programs to approval, becoming the first approved GLP-1/GIP dual agonist
Enrolling 17,604 adults aged 45 or older with established cardiovascular disease and a BMI of 27 or higher (without diabetes), SELECT showed that semaglutide 2.4 mg reduced the composite of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke by 20% over a mean follow-up of nearly 40 months
Both compounds share a proposed mechanism of action and are considered structurally similar
Depends on your doctors prescription